Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.

Peripheral T-cell lymphoma not otherwise specified angioimmunoblastic T-cell lymphoma international prognostic index transplant-ineligible

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 11 11 2020
medline: 1 5 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

We retrospectively analyzed the risk factors for outcomes among patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS,

Identifiants

pubmed: 33167741
doi: 10.1080/10428194.2020.1845336
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-827

Auteurs

Satoshi Yamasaki (S)

Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

Hiroatsu Iida (H)

Department of Hematology and Oncology Research, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Isao Yoshida (I)

Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

Takuya Komeno (T)

Department of Hematology, National Hospital Organization Mito Medical Center, Ibarakimachi, Japan.

Morio Sawamura (M)

Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.

Morio Matsumoto (M)

Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.

Naoshiro Sekiguchi (N)

Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Japan.

Terutoshi Hishita (T)

Department of Hematology, National Hospital Organization Himeji Medical Center, Himeji, Japan.

Kazutaka Sunami (K)

Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.

Takeshi Shimomura (T)

Department of Hematology, National Hospital Organization Hiroshimanishi Medical Center, Otake, Japan.

Hiroshi Takatsuki (H)

Department of Hematology, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.

Shinichiro Yoshida (S)

Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.

Maki Otsuka (M)

Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.

Takeharu Kato (T)

Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.

Yoshiaki Kuroda (Y)

Department of Hematology, National Hospital Organization Hiroshimanishi Medical Center, Otake, Japan.

Tadashi Ooyama (T)

Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.

Yasuhiro Suzuki (Y)

Department of Hematology and Oncology Research, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Koichi Ohshima (K)

Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.

Hirokazu Nagai (H)

Department of Hematology and Oncology Research, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Hiromi Iwasaki (H)

Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH